ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,507Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 1571

$1.98M Total Retail Price of All Prescriptions

Rank: 13 out of 1571

1,637 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

4% of this provider’s 1,637 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

17% of this provider’s 19,576 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

59% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$96 was the average price of a prescription from this provider, compared to $99 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
AVODART 2,924 2,865 10 1 40
TAMSULOSIN HCL 2,748 2,546 10 2 11
VESICARE 2,595 2,502 10 3 75
PREMARIN 2,029 1,979 R 10 4 109
RAPAFLO 1,247 1,177 10 5 131
IMIPRAMINE HCL 1,228 1,214 R 10 6 202
LEVOFLOXACIN 998 918 10 7 79
ENABLEX 958 914 10 8 198
ALFUZOSIN HCL 723 659 10 9 214
DETROL LA 530 523 10 10 246
CIPROFLOXACIN HCL 381 328 11 38
UROXATRAL 355 310 10 12 369
NITROFURANTOIN MONO-MACRO 333 315 13 181
TERAZOSIN HCL 278 278 14 137
JALYN 230 230 15 259
SANCTURA XR 185 185 10 16 464
TOVIAZ 184 181 10 17 402
POTASSIUM CITRATE 177 155 18 340
FINASTERIDE 177 174 18 30
DESMOPRESSIN ACETATE 166 166 10 20 291
AMITIZA 147 147 21 359
DOXAZOSIN MESYLATE 143 143 22 84
NITROFURANTOIN 139 133 23 213
OXYBUTYNIN CHLORIDE ER 138 135 24 140
CEPHALEXIN 128 122 25 126
BETHANECHOL CHLORIDE 120 107 26 254
ESTRACE 119 115 R 27 343
ELMIRON 112 105 28 399
TROSPIUM CHLORIDE 102 101 29 539
SULFAMETHOXAZOLE-TRIMETHOPRIM 101 89 30 86
FLUCONAZOLE 99 92 31 326
ALLOPURINOL 85 73 32 36
MEGESTROL ACETATE 78 78 R 33 145
OXYBUTYNIN CHLORIDE 71 71 34 235
FLOMAX 71 71 10 34 578
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 30, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.